GGrantIndex
← Leaderboards

Charles Stanley Venuto

University Of Rochester

$3,248,212
Attributed
$5,110,496
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY201524
$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$5,110,496 · 5

By mechanism

R33$1,666,423 · 1
RF1$1,155,000 · 1
R61$1,145,753 · 1
K23$719,820 · 1
R21$423,500 · 1

Top collaborators

Most similar at University Of Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsObservational StudyTreatment StrategyMethodologyClinical ResearchResearch PersonnelPharmaceutical PreparationsComplexLearningPatternResponseSourceQuality Of LifeParkinson DiseaseFollow-UpBaseFutureSample SizeData SetParticipantClinical PhenotypeNervous System DisorderHeterogeneityRecommendation

Grant awards (13)

Advancing Personalized Medicine in PD Using Harmonized Multi-Site Clinical Data$472,189
R33 · FY2024 · NS · contact PI
Racial and Ethnic Differences of Non-Motor Symptoms in Parkinson's Disease$423,500
R21 · FY2024 · NS · contact PI
Advancing personalized medicine in PD using harmonized multi-site clinical data$75,000
R33 · FY2024 · NS
Advancing personalized medicine in PD using harmonized multi-site clinical data$562,637
R33 · FY2023 · NS
Advancing personalized medicine in PD using harmonized multi-site clinical data$556,597
R33 · FY2022 · NS
Advancing personalized medicine in PD using harmonized multi-site clinical data$631,099
R61 · FY2021 · NS
Comprehensive Multivariable Deep Learning Models to Identify Predictors of Cognitive Change in PD$1,155,000
RF1 · FY2020 · NS · contact PI
Advancing personalized medicine in PD using harmonized multi-site clinical data$514,654
R61 · FY2020 · NS
Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients$139,410
K23 · FY2019 · AI · contact PI
Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients$138,978
K23 · FY2018 · AI · contact PI
Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients$149,818
K23 · FY2017 · AI · contact PI
Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients$140,233
K23 · FY2016 · AI · contact PI
Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients$151,381
K23 · FY2015 · AI · contact PI